Gardiner Harris investigates Johnson & Johnson’s corporate history and its public reputation for benevolence, focusing on patient-safety questions raised by the company’s products and business practices. The inquiry grew from a 2004 encounter with a company sales representative and ranges across baby powder litigation, Tylenol, Risperdal, cancer treatment, and fentanyl promotion. Harris also looks beyond the manufacturer to alleged shortcomings in the FDA’s consumer-protection role and to media coverage that may have overstated the force of regulatory action against drug companies. The book examines how corporations, regulators, medicine, and journalism influence public confidence, what patients know, and whom they trust.
Reading profile
i About this profile
Collected’s assessment, not reader ratings. Complexity runs from 1 (least demanding) to 5 (most demanding).
Writing
How much attention the sentences and language require.
Ideas
How much interpretation or abstract reasoning the book asks of you.
Structure
How much you need to keep track of speakers, timelines and connections.
Background knowledge
Prior knowledge needed to follow the book, beyond what it explains.
Emotional intensity
Emotional pressure, from gentle (1) to intense (5). Separate from difficulty.